Your browser doesn't support javascript.
loading
A CpG island methylator phenotype in acute myeloid leukemia independent of IDH mutations and associated with a favorable outcome.
Kelly, A D; Kroeger, H; Yamazaki, J; Taby, R; Neumann, F; Yu, S; Lee, J T; Patel, B; Li, Y; He, R; Liang, S; Lu, Y; Cesaroni, M; Pierce, S A; Kornblau, S M; Bueso-Ramos, C E; Ravandi, F; Kantarjian, H M; Jelinek, J; Issa, J-Pj.
Afiliación
  • Kelly AD; Fels Institute for Cancer Research and Molecular Biology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
  • Kroeger H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Yamazaki J; Fels Institute for Cancer Research and Molecular Biology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
  • Taby R; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Neumann F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Yu S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lee JT; Fels Institute for Cancer Research and Molecular Biology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
  • Patel B; Fels Institute for Cancer Research and Molecular Biology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
  • Li Y; Fels Institute for Cancer Research and Molecular Biology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
  • He R; Genomics Facility, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Liang S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lu Y; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Cesaroni M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Pierce SA; Fels Institute for Cancer Research and Molecular Biology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
  • Kornblau SM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Bueso-Ramos CE; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ravandi F; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Jelinek J; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Issa JP; Fels Institute for Cancer Research and Molecular Biology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
Leukemia ; 31(10): 2011-2019, 2017 10.
Article en En | MEDLINE | ID: mdl-28074068
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Islas de CpG / Metilación de ADN Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Islas de CpG / Metilación de ADN Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos